Construction and chemotherapeutic potential of carboxypeptidase-A/monoclonal antibody conjugate
- 31 December 1991
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 31, 3-12
- https://doi.org/10.1016/0065-2571(91)90005-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Activation of prodrugs by antibody‐enzyme conjugates: a new approach to cancer therapyThe FASEB Journal, 1990
- The First Bagshawe lecture: Towards generating cytotoxic agents at cancer sitesBritish Journal of Cancer, 1989
- Carboxypeptidase-mediated release of methotrexate from methotrexate .alpha.-peptidesBiochemistry, 1989
- Selective Cytotoxicity of Carboxypeptidase-activated Methotrexate ex-PeptidesPteridines, 1989
- Chemotherapeutic potential of methotrexate peptidesAdvances in Enzyme Regulation, 1988
- A cytotoxic agent can be generated selectively at cancer sitesBritish Journal of Cancer, 1988
- The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitroBritish Journal of Cancer, 1986
- The Porcine Pancreatic Carboxypeptidase A SystemJournal of Biological Chemistry, 1963